Shimizu, Y., Suzuki, T., Yoshikawa, T., Endo, I., & Nakatsura, T. (2019). Next-Generation Cancer Immunotherapy Targeting Glypican-3. Front Oncol.
Citação norma ChicagoShimizu, Yasuhiro, Toshihiro Suzuki, Toshiaki Yoshikawa, Itaru Endo, and Tetsuya Nakatsura. "Next-Generation Cancer Immunotherapy Targeting Glypican-3." Front Oncol 2019.
ציטוט MLAShimizu, Yasuhiro, et al. "Next-Generation Cancer Immunotherapy Targeting Glypican-3." Front Oncol 2019.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.